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Summary. Neuroendocrine turnors (NETs) are a 
heterogeneous group of neoplasms. They are relatively 
uncommon and characterised by a relatively indolent 
clinical course. The indolent nature of NETs has long 
been enigmatic and recent advances in apoptosis 
research have led to speculation regarding the role of 
programmed cell death in NET tumorigenesis. It is 
hoped that a fundamental molecular understanding will 
help explain these variant behaviors that are so evident 
to the clinician, and ultimately yield novel and more 
effective therapies. 
Recent studies have demonstrated that deregulation 
of programmed cell death may be a critical component 
in the multistep tumorigenesis of NETs and that the 
frequent expression of the BCL-2 oncoprotein in these 
tumors may contribute to their pathogenesis. The genetic 
complementation of simultaneously deregulated BCL-2 
and c-MYC may be implicated in the multistep 
tumorigenesis of human NETs. It is also clear that 
numerous cellular gene products can and will be shown 
to impact upon apoptosis in NETS; some of these may 
even be molecules identified as oncoproteins or tumor 
suppressors. The major challenge will be to ascribe 
primary pathogenetic significance to tumor-associated 
derangements in expression of these molecules, and 
hopefully to then exploit  our knowledge toward 
therapeutic benefit. 
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Introduction 
It is widely recognized that alterations in oncogenes 
and tumor suppressor genes may result in enhanced rates 
of cellular proliferation. More recently, i t  has become 
clear that genetic regulation of apoptosis is also of 
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critical importance during tumorigenesis and that 
oncogene and tumor suppressor genes can regulate the 
rate, or susceptibility of cells to undergo apoptosis 
(McDonnell, 1993; Williams and Smith, 1993). 
The specific application of general principles of 
neoplasia to neuroendocrine tumors (NETs) has been a 
productive area of research and has already begun to be 
translated into direct clinical relevance, a process that is 
certain to accelerate. Neuroendocrine tumorigenesis also 
involves some special, if not unique, features which 
must be considered in moving toward the goal of a full 
understanding of its origins. NETs are a heterogeneous 
group of neoplasms which arise from a diverse cell 
system that shares histologic and biochemical features 
(Bolande, 1974; Pearse, 1980). They are relatively 
uncommon and characterised by a relatively indolent 
clinical course. These tumors secrete active hormones 
and may be associated with distinctive clinical 
syndromes. Despite their rather uniform histological 
pattern, these tumors often display a remarkable degree 
of intertumoral and intratumoral heterogeneity and there 
are considerable differences in their behavior and in their 
responsiveness to therapy. The initial genetic changes in 
the development of the familial multiple endocrine 
neoplasia (MEN) syndromes (MEN 1 and MEN 2) have 
recently been characterised (Eng, 1996; 
Chandrasekharappa et al., 1997; Eng and Mulligan, 
1997; Lemmens et al., 1997). Somatic mutations of these 
genes have also been identified in a subset of sporadic 
NETs (Debelenko et a1,.1997a,b; Eng and Mulligan, 
1997; Heppner et al., 1997; Zhuang et al., 1997; Prezant 
et al., 1998; Tanaka et al., 1998). However, little is 
known about the molecular pathogenesis of the sporadic 
variants of the tumors which account for the majority of 
NETs. Clearly, other etiologies need to be sought. 
Apoptosis  is a ubiquitous physiologic and 
genetically controlled mode of cell death and an 
important feature in many normal biological processes, 
such as embryogenesis, morphogenesis, development of 
the immune system, cell maturation and differentiation. 
Apoptosis plays a complementary but opposite role to 
mitosis in the regulation of tissue homeostasis and is 
distinct from necrosis, the other type of cell death (Kerr 








